The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: Chemotherapy-associated liver injury is a major cause for concern when treating patients with colorectal liver metastases. The aim of this review was to determine the pathological effect of specific chemotherapy regimens on the hepatic parenchyma as well as on surgical morbidity, mortality and overall survival. METHODS: A systematic review of the published literature and a meta-analysis were performed. For each of the variables under consideration, the effects of different chemotherapy regimens were determined by calculation of relative risks by a random-effects model. RESULTS: Hepatic parenchymal injury is regimen specific, with oxaliplatin-based regimens being associated with grade 2 or greater sinusoidal injury (number needed to harm 8; 95 % confidence interval [CI] 6.4-13.6), whereas irinotecan-based regimens associated with steatohepatitis (number needed to harm 12; 95 % CI 7.8-26). The use of bevacizumab alongside FOLFOX reduces the risk of grade 2 or greater sinusoidal injury (relative risk 0.34; 95 % CI 0.15-0.75). CONCLUSIONS: Chemotherapy before resection of colorectal liver metastases is associated with an increased risk of regimen-specific liver injury. This liver injury may have implications for the functional reserve of the liver for patients undergoing major hepatectomy for colorectal liver metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 4×
“The presence of liver injury was defined according to histological criteria as follows: hepatic steatosis (the presence of either macro- or microvesicular steatosis of all grades); steatosis [30 % (hepatic steatosis involving more than 30 % of hepatocytes); steatohepatitis (the presence of the combination of steatohep…”
BackgroundMethodInfluentialSteatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery
Stockmann, M., Lock, J. F., Malinowski, M., Niehues, S. M., Seehofer, D., & Neuhaus, P. (2010) · HPB · doi:10.1111/j.1477-2574.2009.00151.x · Cited by 260
Cited by
Current evidence on posthepatectomy liver failure: Comprehensive review
Sparrelid, E., Olthof, P. B., Dasari, B. V. M., Erdmann, J. I., Santol, J., Starlinger, P., & Gilg, S. (2022) · BJS Open · doi:10.1093/bjsopen/zrac142 · Cited by 88
Current Surgical Management Strategies for Colorectal Cancer Liver Metastases
Ivey, G. D., Johnston, F. M., Azad, N. S., Christenson, E. S., Lafaro, K. J., & Shubert, C. R. (2022) · Cancers · doi:10.3390/cancers14041063 · Cited by 70
Stevenson, H. L., Prats, M. M., & Sasatomi, E. (2017) · BMC Cancer · doi:10.1186/s12885-016-2998-2 · Cited by 37
Metadata
- Authors
- Robinson, S. M., Wilson, C. H., Burt, A. D., Manas, D. M., & White, S. A.
- Venue
- Annals of Surgical Oncology
- Published
- 2012-07-06
- Volume
- 19
- Issue
- 13
- Pages
- 4287-4299
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W1975010709
- Cited by
- 228
- References
- 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.1245/s10434-012-2438-8
- The paper
- Robinson, S. M., Wilson, C. H., Burt, A. D., Manas, D. M., & White, S. A. (2012). Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-012-2438-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.